Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03507439 · ClinicalTrials.gov registry record · NA
REALIsM-HF Pilot Study
A NA study, sponsored by Bayer.
- Completed
- Registry status
- NA
- Development phase
- 27
- Enrollment target
NCT03507439 is a NA study that has completed, run by Bayer. The registered enrollment target is 27 participants.
The verdict
NCT03507439, a NA study, has completed, sponsored by Bayer.
- COMPLETED
- Registry status
- NA
- Development phase
- 27 participants
- Enrollment target
Study Summary
The study aims to explore two marketed devices providing a multimarker monitoring including physical activity under real-life conditions in patients with heart failure with preserved ejection fraction (HFpEF) and with heart failure and reduced ejection fraction (HFrEF). It aims to identify potential novel endpoints for future heart failure trials by exploring clinically relevant changes over time and correlations/associations with conventional endpoints such as the six minute walking distance (6MWD), biomarkers and clinical events. Furthermore, it aims to address the challenges and feasibility of implementing device based measurements under real-life conditions.
Interventions
- DEVICE AVIVO Mobile Patient Management (MPM) System
- DEVICE VitalPatch biosensor
- DEVICE DynaPort Move Monitor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 27 participants |
| Start Date | 2018-04-06 |
| Est. Completion | 2021-03-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03507439
The ClinicalTrials.gov registry entry for NCT03507439 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 27 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Bayer, which has 591 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which AVIVO Mobile Patient Management (MPM) System is the first listed.
NCT03507439 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03507439 about?
NCT03507439 is a clinical study titled "REALIsM-HF Pilot Study". The study aims to explore two marketed devices providing a multimarker monitoring including physical activity under real-life conditions in patients with heart failure with preserved ejection fraction (HFpEF) and with heart failure and reduced ejection fraction (HFrEF). It aims to identify potential...
What is the current status of trial NCT03507439?
This trial is currently completed. It is a NA study. The enrollment target is 27 participants. The study started on 2018-04-06. Estimated completion is 2021-03-12.
What interventions are being tested in trial NCT03507439?
The interventions under investigation include: AVIVO Mobile Patient Management (MPM) System (DEVICE), VitalPatch biosensor (DEVICE), DynaPort Move Monitor (DEVICE).
Who is sponsoring clinical trial NCT03507439?
This trial is sponsored by Bayer, which has 591 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.